Results 81 to 90 of about 1,064,024 (134)
BackgroundCardiovascular disease, with its feared primary presentation of acute myocardial infarction (AMI), remains the leading cause of morbidity and mortality globally.
Katarina Mars (18661267)
core +1 more source
Aim To verify the usefulness of current recommended level of target exercise heart rate (HR) and of different HR-based methods for calculating target HR in patients with and without beta-blocker treatment. Methods We studied 53 patients not treated with
Villelabeitia Jaureguizar, Koldobika +3 more
core +1 more source
The paper presents modern views on beta-blocker therapy in clinical practice. The beta-blocker group is heterogeneous in terms of clinical usage.
D. V. Nebieridze +3 more
doaj
Aims The efficacy of beta‐blockers in cardiac amyloidosis (CA) is unclear, and concerns persist that neurohormonal blockade could worsen symptoms of heart failure.
Chun Shing Kwok +8 more
doaj +1 more source
Background Cardiovascular disease, with its feared primary presentation of acute myocardial infarction (AMI), remains the leading cause of morbidity and mortality globally.
Mars, K,, Katarina Mars (18661267)
core +1 more source
Management of Infantile Hemangiomas in the Beta-blocker Era
Supplementary data for Paradigm Shift in the Management of Infantile Hemangiomas in the Beta-blocker Era: A Retrospective Cohort ...
Fernandez Faith, Esteban
core +1 more source
Endoscopic Band Ligation as an Unmeasured Confounder in the Beta-Blocker-PVT Association. [PDF]
Feng J, Liu L, Gao H.
europepmc +1 more source
Beta-blocker exposure and dobutamine hyperaemia in heart failure with reduced ejection fraction. [PDF]
Hasbak P, Berg RMG.
europepmc +1 more source
Beta-Blocker Discontinuation in Acute Heart Failure: A Systematic Review and Meta-Analysis. [PDF]
Alaeiilkhchi N +7 more
europepmc +1 more source
Beta-blocker therapy after myocardial infarction: an umbrella review. [PDF]
Cataldo-Miranda P +10 more
europepmc +1 more source

